POSTER: CLL-403 Real-World Dosing Patterns and Time to Next Treatment for Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With or Without Ibrutinib Dose Reduction Following an Adverse Event
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
CLL,chronic lymphocytic leukemia/small lymphocytic lymphoma,ibrutinib,time to next treatment,dose reduction,real-word evidence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要